Kelajakdagi narxning foydaga nisbati: optioncarehealth.com (OPCH)

Option Care (OPCH) grafik logotipi

Option Care Health (OPCH) murakkab uy sharoitidagi davolash xavfsizligining kafolati sifatida investorlarni jalb qilmoqda. Kompaniyaning forward P/E koeffitsiyenti ushbu tendentsiyani vizuallashtiradi, bunda 15.20 parametrning joriy qiymati vazifasini o'taydi. Ushbu ishonch yuqori almashinuv xarajatlariga ega yopiq tibbiy ekotizimning yaratilishi, shuningdek, bemorlarning shifoxonaga yotqizilishi orqali tejovlar hisobiga sug'urta kompaniyalari ustidan narxlarni belgilash imkoniyati bilan mustahkamlanmoqda.

Option Care Health, Inc. - OPCH Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 12.11.2026)

Option Care Corp - tahliliy kesimlar va asosiy koʻrsatkichlar (OPCH)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Option Care Health, Inc.
optioncarehealth.com brend mahsuloti

Professional menejerlar bozor narxi kutilayotgan daromadlar nisbatida adolatli ekanligini baholash uchun fundamental filtrlardan foydalanadilar. Option Care Health (OPCH) kompaniyasining 15.20 ga teng bo'lgan joriy forward P/E ko'rsatkichi aksiya narxini prognoz qilingan daromad bilan solishtiradi, bu esa sovuq zanjir logistikasining samaradorligiga va Option Care Health distribyutsiya tarmoqlarining daromadliligiga bo'lgan bozor ishonchini aks ettirib, investorlarga qiymat tuzog'i xatarlarini o'z vaqtida aniqlash imkonini beradi.

Asosiy raqobatchilar

Forvard P/E multiplikatori HCA|THC - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Fresenius Medical Care Corp FMS|SOLV: Narxning kelajakdagi foydaga nisbati|EHC: Prognoz qilingan narxning foydaga nisbati|Universal Health Services - Kapitalizatsiyaning kelajakdagi foydaga nisbati|DaVita (DVA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati RadNet Inc (RDNT)|Kelajakdagi narxning foydaga nisbati Surgery Partners Corp|Premier Health - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati EYE (National Vision Holdings)|Kapitalizatsiyaning kelajakdagi foydaga nisbati PGNY|Forvard P/E multiplikatori ARDT (Ardent Health Partners)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Select Medical Corporation (SEM)|ASTH - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Pediatrix Medical|usph.com (USPH) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati PNTG|Prognoz qilingan narxning foydaga nisbati ORGO|NUTX: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori AUNA|Prognoz qilingan narxning foydaga nisbati SBC Medical Group Inc SBC|Forvard P/E multiplikatori EOLS (Evolus, Inc.)|Forvard P/E multiplikatori chs.net CYH|SKIN - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori MDWD (MediWound Ltd.)|BTMD: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Joint (JYNT)|Prognoz qilingan narxning foydaga nisbati DCGO|PIII: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori GANX|EUDA (EUDA Health Holdings) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori BMGL (Basel Medical Group Ltd)|CollPlant (CLGN) - Prognoz qilingan narx-foyda nisbati|Cuprina Holdings (Cayman) Ltd - Forvard P/E multiplikatori|CCM - Forvard P/E multiplikatori|American Shared Hospital Services (AMS) - Kelajakdagi narxning foydaga nisbati|MRM (MEDIROM Healthcare Group Inc.) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ALBT|DHAI (DIH Group) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori XAGE|NIVF (newgenivf.com) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy, Inc. ATIP|CareMax Inc. (CMAX) - Prognoz qilingan narx-foyda nisbati|KDLY - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati MODV|NVOS: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati SunLink Health Systems, Inc.|BACK (IMAC Holdings) - Forvard P/E multiplikatori